License for Use of "Physicians' Current Procedural Terminology", (CPT) Fourth Edition

End User/Point and Click Agreement: CPT codes, descriptions and other data only are copyright 2009 American Medical Association (AMA). All Rights Reserved (or such other date of publication of CPT). CPT is a trademark of the AMA.

You, your employees and agents are authorized to use CPT only as contained in the following authorized materials including but not limited to CGS fee schedules, general communications, Medicare Bulletin, and related materials internally within your organization within the United States for the sole use by yourself, employees, and agents. Use is limited to use in Medicare, Medicaid, or other programs administered by the Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. License to use CPT for any use not authorized here in must be obtained through the AMA, CPT Intellectual Property Services, 515 N. State Street, Chicago, IL 60610. Applications are available at the AMA website.

This product includes CPT which is commercial technical data and/or computer data bases and/or commercial computer software and/or commercial computer software documentation, as applicable which were developed exclusively at private expense by the American Medical Association, 515 North State Street, Chicago, Illinois, 60610. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or computer software and/or computer software documentation are subject to the limited rights restrictions of DFARS 252.227-7015(b)(2)(June 1995) and/or subject to the restrictions of DFARS 227.7202-1(a)(June 1995) and DFARS 227.7202-3(a)June 1995), as applicable for U.S. Department of Defense procurements and the limited rights restrictions of FAR 52.227-14 (June 1987) and/or subject to the restricted rights provisions of FAR 52.227-14 (June 1987) and FAR 52.227-19 (June 1987), as applicable, and any applicable agency FAR Supplements, for non-Department Federal procurements.

AMA Disclaimer of Warranties and Liabilities.

CPT is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. AMA warrants that due to the nature of CPT, it does not manipulate or process dates, therefore there is no Year 2000 issue with CPT. AMA disclaims responsibility for any errors in CPT that may arise as a result of CPT being used in conjunction with any software and/or hardware system that is not Year 2000 compliant. No fee schedules, basic unit, relative values or related listings are included in CPT. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this file/product is with CGS or the CMS and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

CMS Disclaimer

The scope of this license is determined by the AMA, the copyright holder. Any questions pertaining to the license or use of the CPT must be addressed to the AMA. End Users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CPT. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL CONTAINED ON THIS PAGE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

This license will terminate upon notice to you if you violate the terms of this license. The AMA is a third party beneficiary to this license.

POINT AND CLICK LICENSE FOR USE OF "CURRENT DENTAL TERMINOLOGY", ("CDT")

End User License Agreement

THE LICENSE GRANTED HEREIN IS EXPRESSLY CONDITIONED UPON YOUR ACCEPTANCE OF ALL TERMS AND CONDITIONS CONTAINED IN THIS AGREEMENT. BY CLICKING BELOW ON THE BUTTON LABELED "I ACCEPT", YOU HEREBY ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTOOD AND AGREED TO ALL TERMS AND CONDITIONS SET FORTH IN THIS AGREEMENT.

IF YOU DO NOT AGREE WITH ALL TERMS AND CONDITIONS SET FORTH HEREIN, CLICK BELOW ON THE BUTTON LABELED "I DO NOT ACCEPT" AND EXIT FROM THIS COMPUTER SCREEN.

IF YOU ARE ACTING ON BEHALF OF AN ORGANIZATION, YOU REPRESENT THAT YOU ARE AUTHORIZED TO ACT ON BEHALF OF SUCH ORGANIZATION AND THAT YOUR ACCEPTANCE OF THE TERMS OF THIS AGREEMENT CREATES A LEGALLY ENFORCEABLE OBLIGATION OF THE ORGANIZATION. AS USED HEREIN, "YOU" AND "YOUR" REFER TO YOU AND ANY ORGANIZATION ON BEHALF OF WHICH YOU ARE ACTING.

Subject to the terms and conditions contained in this Agreement, you, your employees, and agents are authorized to use CDT-4 only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. Use of CDT-4 is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this agreement. You acknowledge that the ADA holds all copyright, trademark and other rights in CDT-4. You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials.
Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CDT-4 for resale and/or license, transferring copies of CDT-4 to any party not bound by this agreement, creating any modified or derivative work of CDT-4, or making any commercial use of CDT-4. License to use CDT-4 for any use not authorized herein must be obtained through the American Dental Association, 211 East Chicago Avenue, Chicago, IL 60611. Applications are available at the American Dental Association website.
Applicable Federal Acquisition Regulation Clauses (FARS)\Department of Defense Federal Acquisition Regulation Supplement (DFARS) Restrictions Apply to Government use. Please click here to see all U.S. Government Rights Provisions.
ADA DISCLAIMER OF WARRANTIES AND LIABILITIES. CDT-4 is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. No fee schedules, basic unit, relative values or related listings are included in CDT-4. The ADA does not directly or indirectly practice medicine or dispense dental services. The sole responsibility for the software, including any CDT-4 and other content contained therein, is with (insert name of applicable entity) or the CMS; and no endorsement by the ADA is intended or implied. The ADA expressly disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice to you if you violate the terms of this Agreement. The ADA is a third-party beneficiary to this Agreement.
CMS DISCLAIMER. The scope of this license is determined by the ADA, the copyright holder. Any questions pertaining to the license or use of the CDT-4 should be addressed to the ADA. End users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CDT-4. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL COVERED BY THIS LICENSE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

The license granted herein is expressly conditioned upon your acceptance of all terms and conditions contained in this agreement. If the foregoing terms and conditions are acceptable to you, please indicate your agreement by clicking below on the button labeled "I ACCEPT". If you do not agree to the terms and conditions, you may not access or use the software. Instead, you must click below on the button labeled "I DO NOT ACCEPT" and exit from this computer screen.

Print | Bookmark | Font Size: + | –

Local Carrier Payment Allowance Limits for Medicare Part B Drugs – Effective October 1, 2017 through December 31, 2017

Revised: 11.02.17

Note 1: The complete ASP Payment Allowance Limits list can be accessed at the following link: http://www.cms.gov/McrPartBDrugAvgSalesPrice/01a18_2011ASPFiles.asp

Note 2: Payment allowance limits subject to the ASP methodology are based on 2Q12 ASP data.

Note 3: The absence or presence of a HCPCS code and the payment allowance limits in this table does not indicate Medicare coverage of the drug.

Similarly, the inclusion of a payment allowance limit within a specific column does not indicate Medicare coverage of the drug in that specific category. These determinations shall be made by the local Medicare contractor processing the claim.

Note 4: ** - Carrier-priced

HCPCS Code	Short Description	HCPCS Code Dosage	Payment Limit	Notes
90396**	varicella-zoster immune globulin	125 U / 1.25 ML	Invoice
90396**	varicella-zoster immune globulin	625 U / 6.25 ML	Invoice
90736**	Zostavax	Per Carrier Medical Director not covered by Part B.		Added January 2013
A9587**	Gallium ga-68, dotatate, diagnostic,	Per Mci	66.74	Updated pricing 10/2017
A9588**	Fluciclovine f-18, diagnostic	Per Mci	Invoice	Changed pricing to invoice
A9606**	Radium Ra 223 dichloride (Xofigo)	MicroCurie	136.623	Eff:1/1/2015 / Pricing change EFF 10/01/17
J0200**	Alatrofloxacin mesylate	100 MG	Invoice
J0270**	Alprostadil, 1.25 MCG	Considered self-administered.
J0275**	Alprostadil Urethral Suppository	Considered self-administered.
J0282**	Amiodarone Hcl	30 MG	0.452
J0380**	metaraminol bitartrate, inj	10 MG	Invoice
J0390**	Chloroquine injection	250 MG	Invoice
J0395**	Arbutamine HCl injection	1 MG	Invoice
J0520**	Bethanechol chloride inject	Oral drug considered part of procedure in physician's office.
J0620**	Calcium glycerophosphate/Calcium lactate	10 ML	Invoice
J0695**	Ceftolozane 50mg and Tazobactam 25mg	50mg/25mg	Invoice
J0714**	Ceftazidime and Avibactam	0.5g/0.125g	Invoice
J0715**	Ceftizoxime sodium / 500 MG	500 MG	Invoice
J1130**	Diclofenac sodium (Dyloject)	0.5 mg	$ 0.223	Added 05/2017
J1324**	Enfuvirtide	Considered self-administered.
J1443**	Ferric Pyrophosphate Citrate Sol (Triferic)	0.1mg	Invoice
J1590**	Gatifloxacin injection	Considered self-administered.
J1595**	Injection glatiramer acetate	Considered self-administered.
J1675**	Histrelin Acetate	Considered self-administered.
J1680**	fibrinogen concentrate human	100 MG	$ 103.550
J1700**	Hydrocortisone acetate inj	25 MG	$ 0.360
J1710**	Hydrocortisone sodium ph inj	50 MG	Invoice
J1725	Hydroxyprogesterone Caporate			Eff:07/17New codes Q9985 (Makena) &Q9986 (other forms)
J1826**	Interferon beta-1a / 30 mcg (Avonex)	30 mcg	$ 1,542.565
J1830**	Interferon beta-1b / .25 MG	Not covered by carrier.
J1833**	Isavuconazonium Sulfate (Cresemba)	1 MG	0.68
J1890**	Cephalothin sodium injection	1 G	Invoice
J1960**	Levorphanol tartrate	2 MG	$ 3.765
J1990**	Chlordiazepoxide injection	100 MG	Invoice
J2170**	Mecasermin	Considered self-administered.
J2182**	Mepolizumab (Nucala)	1 MG	29.522	Added January 2017/ Updated pricing 07/2017
J2265**	Minocycline Hydrochloride	Considered self-administered.
J2278KD**	Ziconotide injection	1 MCG	Invoice
J2320**	Nandrolone decanoate 50 MG	50 MG	$ 4.452
J2502**	Pasireotide	1 MG	$ 197.867
J2513**	Pentastarch 10% solution	10%	Invoice
J2547**	Peramivir	1 MG	$ 1.678
J2650**	Prednisolone acetate	1 ML	$ 0.342
J2670**	Tolazoline hcl injection	25 MG	Invoice
J2786**	Reslizumab (Cinqair)	1 MG	$ 8.851	Added January 2017
J2840**	Seblipase alfa (Kanuma)	1 MG	$ 530.000	Added January 2017
J2860**	Siltuximab	10 MG	$ 90.947
J2940**	Somatrem injection	Considered self-administered.
J2941**	Somatropin injection	Considered self-administered.
J2950**	Promazine HCL (Sparine)	25MG	Invoice
J3030**	Sumatriptan Succinate	Considered self-administered.
J3110**	Teriparatide injection	Considered self-administered.
J3145**	Testosterone Undecanoate(Aveed)	1 MG	$ 1.166
J3265**	Injection torsemide 10 mg/ml	10 MG	$ 4.000
J3280**	Thiethylperazine maleate, inj	10 MG	Invoice
J3310**	Perphenazine	5 MG	$ 1.476
J7121**	5% Dextrose in lactated ringers	1000 CC	Invoice
J7130**	Hypertonic saline solution	20 CC	Invoice
J7175**	Factor X human (Coagdex) NOTE:0.209 per unit has been added based on the IOM 100-04, Chapter 17, Section 80.4.1 Clotting Factor Furnishing Fee	1 IU	$ 8.827	Added January 2017
J7179**	Von Willebrand factor (recombinant), (Vonvendi) NOTE:0.209 per unit has been added based on the IOM 100-04, Chapter 17, Section 80.4.1 Clotting Factor Furnishing Fee	1 IU	$ 2.189	Added January 2017
J7188**	Factor VIII (Obizur) NOTE:0.202 per unit has been added based on the IOM 100-04, Chapter 17, Section 80.4.1 Clotting Factor Furnishing Fee	1 IU	$ 5.470	Updated pricing 08/2017
J7191**	Factor viii (porcine)	1 IU	Invoice
J7202**	Factor ix, albumin fusion protein, (recombinant),(Idelvion) NOTE:0.209 per unit has been added based on the IOM 100-04, Chapter 17, Section 80.4.1 Clotting Factor Furnishing Fee	1 IU	$ 4.714	Added January 2017
J7207**	Factor viii, (antihemophlic factor, recombinant, (pegylated), Adynovate NOTE:0.209 per unit has been added based on the IOM 100-04, Chapter 17, Section 80.4.1 Clotting Factor Furnishing Fee	1 IU	$ 2.189	Added January 2017
J7209**	Factor viii (antihemophilic factor, recombinant), (Nuwiq) NOTE:0.209 per unit has been added based on the IOM 100-04, Chapter 17, Section 80.4.1 Clotting Factor Furnishing Fee	1 IU	$ 2.000	Added January 2017
J7322**	Hyaluronic acid (Hymovis)	1 MG	$ 19.257	Added January 2017/ Updated pricing 07/2017
J7328**	Hyaluronan or derivative, gel-syn	0.1 MG	$ 2.177
J7340**	Carbidopa 5mg/Levodopa 20mg	5mg/20mg	Invoice
J7604**	Acetylcystein	Considered part of procedure in physician's office.
J7622**	Beclomethasone inhalation sol	Considered part of procedure in physician's office.
J7624**	Betamethasone inhalation sol	Considered part of procedure in physician's office.
J7628**	Bitolterol mes inhal sol con	Considered part of procedure in physician's office.
J7629**	Bitolterol mes inh sol u d	Considered part of procedure in physician's office.
J7633**	Budesonide concentrated sol	Considered part of procedure in physician's office.
J7641**	Flunisolide, inhalation sol	Considered part of procedure in physician's office.
J7648**	Isoetharine hcl inh sol con	Considered part of procedure in physician's office.
J7649**	Isoetharine hcl inh sol u d	Considered part of procedure in physician's office.
J7658**	Isoproterenol hcl inh sol con	Considered part of procedure in physician's office.
J7659**	Isoproterenol hcl inh sol ud	Considered part of procedure in physician's office.
J7668**	Metaproterenol inh sol con	Considered part of procedure in physician's office.
J7680**	Terbutaline so4 inh sol con	Considered part of procedure in physician's office.
J7681**	Terbutaline so4 inh sol u d	Considered part of procedure in physician's office.
J7683**	Triamcinolone inh sol con	Considered part of procedure in physician's office.
J7684**	Triamcinolone inh sol u d	Considered part of procedure in physician's office.
J8561**	Everolimus, 0.25 MG	Should be billed to DMAC.
J9165**	Diethylstilbestrol diphosphate injection	250 MG	Invoice
J9213**	Interferon alfa-2a inj	3 MIL UNITS	Invoice
J9215**	Interferon, alfa-n3	250,000 IU	$ 23.834
J9262**	Omacetaxine Mepesuccinate(Synribo)	0.01 MG	$ 2.529
J9270**	Plicamycin (mithramycin) inj	2.5 MG	Invoice
J9600**	Porfimer Sodium injection	75 MG	$ 20,410.406
Q0174**	Thiethylperazine maleate, 10mg	Should be billed to DMAC.
Q0179**	Ondansetron hcl 9 mg oral	Should be billed to DMAC.
Q0181**	Unspecified oral dosage form, FDA approved presription anti-emetic	Should be billed to DMAC.
Q2026**	Radiesse injection	0.1 ML	Invoice
Q2028**	Sculptra	0.5 MG	Invoice
Q2034**	Agriflu	0.05 ML	Invoice
Q2036**	Flulaval Quadrivalent 3 yrs & >, im	0.05 ML	$ 19.174
Q2039**	Not Otherwise Classified flu vacc, 3 yrs & >, im	0.5 ML	Invoice	Special note regarding Flucelvax: - For dates of service 08/01/2017 through 12/31/2017 Q2039, , if you are filing a claim for the following vaccine: influenza virus vaccine, quadrivalent, ccIIV4, derived from cell cultures, subunit, antibiotic free, 0.5mL dosage, for intramuscular use (Flucelvax, ccIIV4), the allowable amount will be $22.793 per 0.5ml. Effective 01/01/2018 forward use CPT code 90756 for Flucelvax. If drug has a assigned code you must use the correct code.
Q4105**	Integra Omnigraft	1 SQ CM	$ 54.082	Added 10/17
Q4110**	PriMatrix and PriMatrix AG	1 SQ CM	$ 33.668	Added 10/17
Q4118**	Matristem Micromatrix	1 MG	$ 2.433
Q4119**	Matristem Micromatrix	1 SQ CM	$ 2.470
Q4122**	Dermacell	1 SQ CM	Invoice
Q4124**	Oasis Ultra Tri-Layer Wound Matrix	1 SQ CM	$ 11.400
Q4125**	Arthroflex	1 SQ CM	Invoice
Q4126**	Memoderm	1 SQ CM	Invoice
Q4127**	Talymed	1 SQ CM	Invoice
Q4128**	Flex HD or Allopatch HD	1 SQ CM	Invoice
Q4129**	Unite Biomatrix	1 SQ CM	Invoice
Q4130**	Strattice TM	1 SQ CM	Invoice
Q4137**	Amnioexcel or Biodexcel	1 SQ CM	83.952	Pricing added 10/23/2017
Q4138**	Biodfence dryflex	1 SQ CM	Invoice
Q4139*	Amniomatrix or Biodmatrix	1 CC	Invoice
Q4140**	Biodfence	1 SQ CM	Invoice
Q4141**	Alloskin ac	1 SQ CM	Invoice
Q4142**	Xcm Biologic Tissue Matrix	1 SQ CM	Invoice
Q4143**	Repriza	1 SQ CM	Invoice
Q4145**	Epifix	1 MG	Invoice
Q4146**	Tensix	1 SQ CM	Invoice
Q4147**	Architect Extracellular Matrix	1 SQ CM	Invoice
Q4148**	Neox 1k	1 SQ CM	Invoice
Q4149**	Excellagen	0.1 CC	34.200
Q4152**	Dermapure	1 SQ CM	88.113
Q4158**	Kerecis Omega3 Wound (Marigen)	1 SQ CM	38.230	Added pricing 11/02/17
Q4160	NuShield	1 SQ CM	212.000	Added 10/17
Q4161**	Bio-connekt	1 SQ CM	Invoice
Q4162**	Amnio bio, woundex flow	1 SQ CM	Invoice
Q4163**	Amnio bio, woundex	1 SQ CM	Invoice
Q4164**	Helicoll	1 SQ CM	Invoice
Q4165**	Keramatrix	1 SQ CM	Invoice
Q4172**	PuraPly or PuraPly am	1 SQ CM	118.720	Added January 2017
Q4173**	Palingen or Palingen Xplus	1 SQ CM	Invoice	Added 11/02/17
Q4175**	MicroDerm	1 SQ CM	Invoice	Added 10/17
Q9953**	Iron Based Magnetic Resonance Contrast Agent	1 ML	Invoice
Q9955**	Inj perflexane lip micros, ml	1 ML	Invoice
Q9980**	Genvisc	1 MG	9.765
Q9985**	Hydroxyprogesterone Caporate (other forms)		Invoice	Added 10/17
Q9986**	Hydroxyprogesterone Caporate (Makena)	10 MG	$ 32.408	Added 10/17
Q9988**	Platelets, Pathogen Reduced		invoice	Added 10/17

License for Use of "Physicians' Current Procedural Terminology", (CPT) Fourth Edition

AMA Disclaimer of Warranties and Liabilities.

CMS Disclaimer

POINT AND CLICK LICENSE FOR USE OF "CURRENT DENTAL TERMINOLOGY", ("CDT")

Local Carrier Payment Allowance Limits for Medicare Part B Drugs – Effective October 1, 2017 through December 31, 2017

spacer